NV5 Global, Inc. stockholders approved a merger with Acuren Corporation, expected to close in August 2025.
Quiver AI Summary
NV5 Global, Inc. has announced that a majority of its stockholders approved a merger with Acuren Corporation during a Special Meeting held on July 31, 2025. Under the merger agreement, NV5 stockholders will receive approximately $23.00 per share, which includes $10.00 in cash and $13.00 in Acuren stock, with potential adjustments due to a collar feature. Following the merger, NV5 stockholders are expected to own about 40% of the combined company's stock, while Acuren stockholders will own around 60%. The transaction is subject to customary closing conditions and is anticipated to close in August 2025. The press release also includes forward-looking statements regarding the merger and cautions about potential risks and uncertainties.
Potential Positives
- Holders of a majority of NV5's outstanding common stock approved the proposed merger with Acuren, indicating strong support for strategic growth.
- NV5 stockholders are set to receive approximately $23.00 per share in the merger, consisting of both cash and shares of Acuren, reflecting a favorable valuation for shareholders.
- Upon completion of the merger, pre-merger NV5 stockholders are expected to own approximately 40% of the combined company's common stock, ensuring continued participation in the new entity's growth.
- The merger is expected to close promptly in August 2025, suggesting a swift progression towards realizing the anticipated benefits of the transaction.
Potential Negatives
- The projected ownership distribution post-merger indicates that pre-Merger Acuren stockholders will own 60% of the combined company, potentially diluting the influence of NV5 stockholders.
- The merger is subject to customary closing conditions, introducing uncertainty regarding the completion of the deal.
- The forward-looking statements highlight significant risks and uncertainties that could affect the realization of anticipated benefits from the merger.
FAQ
What is the proposed merger between NV5 and Acuren?
The merger involves NV5 acquiring Acuren, resulting in stockholders receiving approximately $23.00 per share.
When is the NV5 and Acuren merger expected to close?
The merger is expected to finalize promptly in August 2025, pending customary closing conditions.
How will ownership be divided after the merger?
Post-merger, NV5 stockholders will own about 40%, while Acuren stockholders will hold approximately 60% of the combined company.
What details are available about the cash and stock distribution?
Stockholders will receive $10.00 in cash and $13.00 in shares of Acuren common stock, subject to adjustments.
Where can I find more information on the merger?
For more details, refer to the definitive joint proxy statement/prospectus filed with the SEC on July 2, 2025.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$NVEE Hedge Fund Activity
We have seen 111 institutional investors add shares of $NVEE stock to their portfolio, and 104 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- EMERALD ADVISERS, LLC removed 702,679 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $13,540,624
- BLACKROCK, INC. added 635,564 shares (+6.7%) to their portfolio in Q1 2025, for an estimated $12,247,318
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 517,740 shares (+1325.2%) to their portfolio in Q1 2025, for an estimated $9,976,849
- BANK OF NEW YORK MELLON CORP added 402,506 shares (+26.6%) to their portfolio in Q1 2025, for an estimated $7,756,290
- SWEDBANK AB removed 400,000 shares (-21.1%) from their portfolio in Q2 2025, for an estimated $9,236,000
- EMERALD MUTUAL FUND ADVISERS TRUST removed 383,146 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $7,383,223
- AMERICAN CENTURY COMPANIES INC added 307,169 shares (+14.3%) to their portfolio in Q1 2025, for an estimated $5,919,146
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NVEE Analyst Ratings
Wall Street analysts have issued reports on $NVEE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Roth MKM issued a "Buy" rating on 02/21/2025
To track analyst ratings and price targets for $NVEE, check out Quiver Quantitative's $NVEE forecast page.
$NVEE Price Targets
Multiple analysts have issued price targets for $NVEE recently. We have seen 2 analysts offer price targets for $NVEE in the last 6 months, with a median target of $26.0.
Here are some recent targets:
- Tate Sullivan from Maxim Group set a target price of $24.0 on 02/21/2025
- Jeff Martin from Roth MKM set a target price of $28.0 on 02/21/2025
Full Release
HOLLYWOOD, Fla., July 31, 2025 (GLOBE NEWSWIRE) -- NV5 Global, Inc. (Nasdaq: NVEE) (“NV5” or the “Company”) , a leading provider of tech-enabled engineering, testing, inspection, and consulting solutions for the built environment, announced today that holders of a majority of its outstanding common stock voted to approve the proposed merger (the "Merger") with Acuren Corporation ("Acuren") at a Special Meeting of Stockholders (the "Special Meeting") held today.
Under the terms of the Agreement and Plan of Merger dated as of May 14, 2025 relating to the Merger, NV5 stockholders will receive approximately $23.00 per share consisting of $10.00 in cash and $13.00 in shares of Acuren common stock at closing, subject to potential adjustment as a result of a 10% collar feature. Upon consummation of the Merger, pre-Merger NV5 stockholders are expected to collectively own up to approximately 40% of the common stock of the combined company on a pro forma basis. Pre-Merger Acuren stockholders are expected to collectively own approximately 60% of the common stock of the combined company on a pro forma basis. The transaction is subject to customary closing conditions, and is expected to close promptly in August 2025.
For more information, please see the definitive joint proxy statement/prospectus filed by NV5 with the Securities and Exchange Commission (the "SEC") on July 2, 2025, as supplemented on July 21.
Forward-Looking Statements
Certain statements in this press release concerning the proposed Merger, including any statements regarding the expected timetable for completing the proposed Merger, and any other statements regarding NV5’s or Acuren’s future expectations, beliefs, plans, objectives, financial conditions, assumptions or future events or performance that are not historical facts are “forward-looking” statements based on assumptions currently believed to be valid. Forward-looking statements are all statements other than statements of historical facts. The words “anticipate,” “believe,” “ensure,” “expect,” “if,” “intend,” “estimate,” “probable,” “project,” “forecasts,” “predict,” “outlook,” “aim,” “will,” “could,” “should,” “would,” “potential,” “may,” “might,” “anticipate,” “likely” “plan,” “positioned,” “strategy,” and similar expressions or other words of similar meaning, and the negatives thereof, are intended to identify forward-looking statements. Specific forward-looking statements include statements regarding the combined company and the expected closing of the proposed Merger. The forward-looking statements are intended to be subject to the safe harbor provided by Section 27A of the Securities Act, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995.
These forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those anticipated, including, but not limited to, the risk that a condition to closing of the proposed Merger may not be satisfied, that either party may terminate the merger agreement or that the closing might be delayed or not occur at all.
Additional factors that could cause results to differ materially from those described above can be found in NV5’s Annual Report on Form 10-K for the year ended December 28, 2024, as amended, which is on file with the SEC and available from NV5’s website at www.nv5.com under the “Investor Relations” tab, and in other documents NV5 files with the SEC; and in Acuren’s Annual Report on Form 10-K for the year ended December 31, 2024, which is on file with the SEC and available from Acuren’ website at www.acuren.com under the “Investor Relations” tab, and in other documents Acuren files with the SEC.
All forward-looking statements speak only as of the date they are made and are based on information available at that time. Neither NV5 nor Acuren assumes any obligation to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements were made or to reflect the occurrence of unanticipated events except as required by federal securities laws. As forward-looking statements involve significant risks and uncertainties, caution should be exercised against placing undue reliance on such statements.
Contact
NV5 Global, Inc.
Jack Cochran
Vice President, Marketing & Investor Relations
Tel: +1-954-637-80483
Email:
[email protected]